Evidence map›Paper›PMID 27363812›Full record

ArticleNature communications2016

Neutrophils mediate Salmonella Typhimurium clearance through the GBP4 inflammasome-dependent production of prostaglandins.

Sylwia D Tyrkalska, Sergio Candel, Diego Angosto, Victoria Gómez-Abellán, Fátima Martín-Sánchez, Diana García-Moreno, Rubén Zapata-Pérez, Álvaro Sánchez-Ferrer, María P Sepulcre, Pablo Pelegrín and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 124 citations in OpenAlex.

  1. Gut microbes · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Natterin bridges IFN-φ1 and non-canonical inflammasome pathways viaFrontiers in cellular and infection microbiology · 2025
    Article
  14. Article
  15. ConcurrentmSphere · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Surface engineeringExploration (Beijing, China) · 2023
    Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sylwia D TyrkalskaFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Sergio CandelFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Diego AngostoFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Victoria Gómez-AbellánFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Fátima Martín-SánchezUnidad de inflamación y Cirugía Experimental, CIBERehd, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, 30120 Murcia, Spain.
Diana García-MorenoFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Rubén Zapata-PérezFacultad de Biología, Departamento de Bioquímica y Biología Molecular A, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Álvaro Sánchez-FerrerFacultad de Biología, Departamento de Bioquímica y Biología Molecular A, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
María P SepulcreFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.
Pablo PelegrínUnidad de inflamación y Cirugía Experimental, CIBERehd, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, 30120 Murcia, Spain.
Victoriano MuleroFacultad de Biología, Departamento de Biología Celular e Histología, Universidad de Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.ORCID http://orcid.org/0000-0001-9527-0211
Universidad de Murcia · ESCentro de Investigación Biomédica en Red · ESInstituto Murciano de Investigación Biosanitaria · ESInstituto de Investigacións Mariñas · ES

Funding

European Research Council 614578
6 · The paper itself

Abstract

Inflammasomes are cytosolic molecular platforms that alert the immune system about the presence of infection. Here we report that zebrafish guanylate-binding protein 4 (Gbp4), an IFNγ-inducible GTPase protein harbouring a C-terminal CARD domain, is required for the inflammasome-dependent clearance of Salmonella Typhimurium (ST) by neutrophils in vivo. Despite the presence of the CARD domain, Gbp4 requires the universal inflammasome adaptor Asc for mediating its antibacterial function. In addition, the GTPase activity of Gbp4 is indispensable for inflammasome activation and ST clearance. Mechanistically, neutrophils are recruited to the infection site through the inflammasome-independent production of the chemokine (CXC motif) ligand 8 and leukotriene B4, and then mediate bacterial clearance through the Gbp4 inflammasome-dependent biosynthesis of prostaglandin D2. Our results point to GBPs as key inflammasome adaptors required for prostaglandin biosynthesis and bacterial clearance by neutrophils and suggest that transient activation of the inflammasome may be used to treat bacterial infections.

Indexed as

AnimalsCaspase Activation and Recruitment DomainGTP-Binding ProteinsInflammasomesInterleukin-8Leukotriene B4MorpholinosNeutrophilsOrganisms, Genetically ModifiedProstaglandin D2ProstaglandinsSalmonella typhimuriumZebrafishGTP-Binding ProteinsInflammasomesInterleukin-8Leukotriene B4MorpholinosProstaglandin D2Prostaglandins

Identifiers

PMID27363812
PMCPMC4932187
OpenAlexW2469507339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.